TLR2 and atherosclerosis: Despite evidence suggesting that L654 and other glycine lipids activate TLR2 signaling, we report here protective effects against hepatic inflammation and atherosclerosis with chronic exposure, particularly in HFD conditions where fecal and serum glycine lipids are reduced.